Dong and colleagues present a retrospective study evaluating risk factors associated with tumor recurrence for patients with non-functional pancreatic neuroendocrine tumors. This study includes over 800 patients from the US Neuroendocrine Study Group. The results of their study indicate that the overall tumor volume as determined by number and size of tumors predicts recurrence. Read more in the most recent August 2020 edition of HPB.

Overall Amount of Cancer Matters for Pancreatic Neuroendocrine Tumors (PNETs)